Baijiu plate strength, mouth cellar line exceeds 10%

Synthetic Biology: Who Will Emerge as the Winner?

The 21st century is the century of biology. Synthetic biology is believed to be a ‘World Changing’ industry. But the potential risks like cost control and commercialization pathways are fatefully tied to the ups and downs of countless investment decisions and the destiny of the many new start-ups getting involved. We look forward to seeing an emerging ‘giant’ on the horizon of this exciting industry.

Haitian Acquires Hong Kong’s Amoy Food to Add an Established Overseas Platform

Foshan Haitian Flavouring and Food（海天味业）has completed the acquisition of all equity interests in Amoy Food Limited（淘大）, the Hong Kong food brand founded in 1908. The deal gives China’s leading condiment producer an established international brand and sales network, rather than requiring it to build overseas distribution market by market.

Kaiying Network Plans Indirect Wemade Stake Through US$298 Million Investment

Kaiying Network（恺英网络）plans to invest an estimated USD 298 million to acquire a 49% interest in an offshore vehicle connected to the proposed takeover of Wemade Co., Ltd., the South Korean game developer and original rights holder of the Legend of Mir IP. If completed, the transaction would give the Chinese publisher an indirect economic interest of about 19.7% in Wemade, based on the buyer vehicle’s planned 40.25% holding.

EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）

Private enterprises are actively embracing the transformative era

Bloomage: Injecting Biotechnology into Beauty Care

Listed on the Chinese Star Market in November 2019, Bloomage was trading at CNY 138.01 as of June 24, 2020, over 38% higher than the IPO price of CNY 100.